EPO Patents = 2

Forward Citations = 10

Loading Chart...

6 inventors (with patents filed for the assignee):

Victor Gurewich (5 out of 11 patents)

Paolo Sarmientos (2 out of 2 patents)

Massimiliano Pagani (2 out of 2 patents)

4. Jian-ning Liu (1 out of 4 patents)

5. Ralph Pannell (1 out of 2 patents)

6. John Noel Williams (1 out of 10 patents)

6 patents: Sort by Forward Citations

1. 12590301 - METHODS FOR SAFE AND EFFECTIVE THROMBOLYSIS USING SEQUENTIAL ADMINISTRATION OF TISSUE PLASMINOGEN ACTIVATOR AND MUTANT PRO-UROKINASE (2026-03-31),

2. 11213574 - Methods for safe and effective thrombolysis using sequential administration of tissue plasminogen activator and mutant pro-urokinase (2022-01-04),

3. 11154596 - Methods for thrombolysis (2021-10-26),

4. 8187592 - C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis (2012-05-29),

5. 7074401 - Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots (2006-07-11),

6. 7070958 - Methods of making pro-urokinase mutants (2006-07-04),

Company Overview

Thrombolytic Science, LLC is a biopharmaceutical company focused on the development of innovative thrombolytic therapies for the treatment of cardiovascular diseases. With a team of experienced researchers and scientists, the company is dedicated to advancing the field of thrombolytic medicine to improve patient outcomes and quality of life. Visit their website for more information on their groundbreaking research and products.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#324 in Cambridge, MA

#2,546 in Massachusetts

#45,007 in US

Cambridge, MA, United States of America

Thrombolytic Science, LLC

Forward Citations = 10

6 inventors:

Victor Gurewich (5 out of 11 patents)

Paolo Sarmientos (2 out of 2 patents)

Massimiliano Pagani (2 out of 2 patents)

4. Jian-ning Liu (1 out of 4 patents)

5. Ralph Pannell (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Thrombolytic Science, LLC. Retrieved from https://idiyas.com/company/thrombolytic-science

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]